Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cells.

Manatunga, Danushika C; de Silva, Rohini M; de Silva, K M Nalin; Wijeratne, Dulharie T; Malavige, Gathsaurie Neelika; Williams, Gareth

Manatunga, Danushika C; de Silva, Rohini M; de Silva, K M Nalin; Wijeratne, Dulharie T; Malavige, Gathsaurie Neelika; Williams, Gareth.

Afiliação

Manatunga DC; Department of Chemistry, University of Colombo, Colombo, 00300, Sri Lanka.
de Silva RM; Department of Chemistry, University of Colombo, Colombo, 00300, Sri Lanka. rohini@chem.cmb.ac.lk.
de Silva KMN; Department of Chemistry, University of Colombo, Colombo, 00300, Sri Lanka.
Wijeratne DT; Sri Lanka Institute of Nanotechnology (SLINTEC), Nanotechnology & Science Park, Mahenwatte, Pitipana, Homagama, 10206, Sri Lanka.
Malavige GN; Centre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, 10250, Sri Lanka.
Williams G; Centre for Dengue Research, Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, 10250, Sri Lanka.

Chem Cent J ; 12(1): 119, 2018 Nov 23.

Article em En | MEDLINE | ID: mdl-30470922

Palavras-chave

6-Gingerol; Doxorubicin; HEpG2; Hydroxyapatite; MCF-7

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Chem Cent J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Sri Lanka